KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Cme (CME) Net Income towards Common Stockholders (2016 - 2025)

Historic Net Income towards Common Stockholders for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $896.6 million.

  • Cme's Net Income towards Common Stockholders fell 52.15% to $896.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.7 billion, marking a year-over-year increase of 860.87%. This contributed to the annual value of $3.5 billion for FY2024, which is 928.87% up from last year.
  • According to the latest figures from Q3 2025, Cme's Net Income towards Common Stockholders is $896.6 million, which was down 52.15% from $1.0 billion recorded in Q2 2025.
  • In the past 5 years, Cme's Net Income towards Common Stockholders ranged from a high of $1.0 billion in Q2 2025 and a low of $510.3 million during Q2 2021
  • For the 5-year period, Cme's Net Income towards Common Stockholders averaged around $778.7 million, with its median value being $804.3 million (2023).
  • Its Net Income towards Common Stockholders has fluctuated over the past 5 years, first skyrocketed by 12515.19% in 2021, then tumbled by 2756.61% in 2022.
  • Quarter analysis of 5 years shows Cme's Net Income towards Common Stockholders stood at $605.9 million in 2021, then increased by 3.98% to $630.0 million in 2022, then grew by 27.67% to $804.3 million in 2023, then grew by 7.39% to $863.7 million in 2024, then increased by 3.81% to $896.6 million in 2025.
  • Its Net Income towards Common Stockholders stands at $896.6 million for Q3 2025, versus $1.0 billion for Q2 2025 and $944.2 million for Q1 2025.